-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QrmSP4uaNzIuLYAwJSGZ1v+ca4/iBuhmPWaWze488CBp9bGlYaHlTn9Af8JXMq5n ayQUt7PP3KWPM/9/GZDJmw== 0001020488-05-000160.txt : 20050929 0001020488-05-000160.hdr.sgml : 20050929 20050929110545 ACCESSION NUMBER: 0001020488-05-000160 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050630 FILED AS OF DATE: 20050929 DATE AS OF CHANGE: 20050929 EFFECTIVENESS DATE: 20050929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DOTRONIX INC CENTRAL INDEX KEY: 0000351809 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS MANUFACTURING INDUSTRIES [3990] IRS NUMBER: 411387074 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-09996 FILM NUMBER: 051110076 BUSINESS ADDRESS: STREET 1: 160 FIRST ST S E CITY: NEW BRIGHTON STATE: MN ZIP: 55112-7894 BUSINESS PHONE: 6126331742 MAIL ADDRESS: STREET 1: 160 FIRST STREET SE CITY: NEW BRIGHTON STATE: MN ZIP: 55112 NT 10-K 1 dotronix-nt10k_063005.htm

SECURITIES AND EXCHANGE COMMISSION

 
   

Washington, D.C. 20549

 
 

SEC FILE NUMBER

FORM 12b-25

 
 

0-99996

NOTIFICATION OF LATE FILING

CUSIP NUMBER

   

(Check One): [X ] Form 10-K and Form 10-KSB [  ] Form 20-F [  ] Form 11-K

258564 10 3

[   ] Form 10-Q and Form 10-QSB [  ] Form N-SAR

 

For Period Ended: June 30, 2005

[ ] Transition Report on Form 10-K

[ ] Transition Report on Form 20-F

[ ] Transition Report on Form 11-K

[ ] Transition Report on Form 10-Q

[ ] Transition Report on Form N-SAR

For the Transition Period Ended:

Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:


PART I - REGISTRANT INFORMATION

Full Name of Registrant

Dotronix, Inc.

Former Name if Applicable

Address of Principal Executive Office (Street and Number)

160 First Street Southeast

City, State and Zip Code

New Brighton, MN 55112-7894


PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

[ X ]    
(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K and Form 10-KSB, 20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach Extra Sheets if Needed) See attached


PART IV - OTHER INFORMATION

(1)     Name and telephone number of person to contact in regard to this notification

Robert V. Kling
(Name)
651
(Area Code)
633-1742
(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed? If answer is no, identify report(s).       [X  ]  Yes [  ]   No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?       [  ]  Yes [ X ]   No

If so, attach an If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Dotronix, Inc.    
         
    (Name of Registrant as Specified in Charter)    
   

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: September 29, 2005   By: /s/  Robert V. Kling
  Chief Financial Officer


September 29, 2005

Dotronix, Inc.
File No. 0-9996

Attachment to SEC form 12b-25
Part III

The Registrant needed more time than originally anticipated to complete its
financial statements for the year ending June 30, 2005.





-----END PRIVACY-ENHANCED MESSAGE-----